Evidence map›Paper›PMID 41460476›Full record

Observational studyBreast cancer (Tokyo, Japan)2026

Postoperative course and safety profile of the suture scaffold technique in breast-conserving surgery: a single-institution observational study.

Reiko Mitsueda, Yasuyo Ohi, Yukari Mochitomi, Rie Takaki, Megumi Furukawa, Akiko Arimura, Yoshitaka Fujiki, Naomi Gondo, Junko Kawano, Shuichi Kanemitsu and 8 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Breast cancer (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Reiko MitsuedaDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan.
Yasuyo OhiDepartment of Pathology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Japan.
Yukari MochitomiDepartment of Clinical Laboratory, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Japan.
Rie TakakiDepartment of Clinical Laboratory, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Japan.
Megumi FurukawaDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan.
Akiko ArimuraDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan.
Yoshitaka FujikiDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan.
Naomi GondoDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan.
Junko KawanoDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan.
Shuichi KanemitsuDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan.
Megumi TeraokaDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan.
Yoshiaki RaiDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan.
Sakurako YanaseDepartment of Plastic Surgery, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Japan.
Hayahito SakaiDepartment of Plastic Surgery, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Japan.
Sugako NomotoDepartment of Plastic Surgery, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Japan.
Yoshiaki SagaraDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan.
Shinji OhnoDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan.
Yasuaki SagaraDepartment of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, 3-31 Matsubara Cho, Kagoshima Shi, Kagoshima, 892-0833, Japan. yas794@mail.harvard.edu.ORCID http://orcid.org/0000-0001-5705-1739

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe suture scaffold technique (SST) is a simple oncoplastic method used during breast-conserving surgery (BCS) to preserve breast contour by bridging the resection cavity. Although favorable cosmetic outcomes have been reported, its healing process and complication profile remain insufficiently evaluated.

methodsThis retrospective single-institution study included patients who underwent BCS with oncoplastic procedures between 2017 and 2022. Postoperative healing after SST was assessed by short-term ultrasonography, mid-term histopathology, and long-term ultrasonographic and elastographic evaluations, with the breast glandular flap technique (BGFT) as comparator. Complications were assessed at approximately one month, classified by the Clavien–Dindo system, and compared among SST, BGFT, and no oncoplastic technique (NOT). Risk factors were analyzed using logistic regression adjusted for clinical covariates.

resultsUltrasonography on postoperative day 8 after SST revealed serous fluid retention and fibrin-like fibers around scaffold sutures with connective tissue ingrowth. Histopathology of re-excised specimens at 1–4 months showed fibrin deposition and granulation tissue, which matured into fibrotic scar tissue. Long-term ultrasonography (mean follow-up 4.4 years) demonstrated slightly more evident scar formation in the SST group compared with BGFT, with cysts that mostly resolved spontaneously. Shear-wave elastography showed no significant difference in scar stiffness (1.81 ± 0.56 vs. 1.49 ± 0.48 m/s; p = 0.065). Among 643 patients (421 SST, 134 BGFT, 88 NOT), 11 clinically significant complications (1.7%) were observed, including 7 grade 2 infections requiring antibiotics and 4 grade 3 events requiring intervention. Multivariate analysis found no significant intergroup differences in complication rates.

conclusionsSST is a safe and technically simple oncoplastic option that preserves cosmetic outcomes without increasing complications. It may serve as a practical alternative to conventional oncoplastic techniques in BCS.

Indexed as

Breast NeoplasmsMastectomy, SegmentalPostoperative ComplicationsSuture TechniquesAdultAgedFemaleHumansMiddle AgedRetrospective StudiesBreast cancerBreast-conserving surgeryOncoplastic surgerySuture Scaffold Technique

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.